Gerresheimer AG

XTRA:GXI 株式レポート

時価総額：€884.2m

Gerresheimer 将来の成長

Future 基準チェック /36

Gerresheimer利益と収益がそれぞれ年間42.7%と5.1%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に8.2% 45.9%なると予測されています。

主要情報

42.7%

収益成長率

45.92%

EPS成長率

Life Sciences 収益成長20.1%
収益成長率5.1%
将来の株主資本利益率8.22%
アナリストカバレッジ

Good

最終更新日16 Jun 2026

今後の成長に関する最新情報

Recent updates

ナラティブの更新 • Jun 16

GXI: Reporting Delays Accounting Scrutiny And Bormioli Overhang Will Cap Near Term Confidence

Gerresheimer's updated analyst price target has come down to €26.80 from €34.10. Analysts point to delayed results, accounting concerns and ongoing overhangs around Bormioli as key reasons for the reset.
ナラティブの更新 • Jun 01

GXI: Reporting Delays And Accounting Concerns Will Pressure Long Term Confidence

Analysts have trimmed their price targets on Gerresheimer, with one cut from €34.10 to €26.80 contributing to a modest reduction in the modelled fair value from €24.40 to about €23.37, as concerns around delayed results, accounting issues, and the Bormioli overhang weigh on sentiment. Analyst Commentary Recent research has shifted toward a more cautious stance on Gerresheimer, with several firms moving to neutral ratings and cutting price targets to around €26.80 from about €34.10.
ナラティブの更新 • May 03

GXI: FY25 Warning And Deferred Results Will Drive Further Share Weakness

Analysts have trimmed their average price target for Gerresheimer to about €12.90 from €29, citing reduced short- and mid-term estimates following the recent FY25 warning and slightly softer expectations compared with the low end of the company's FY26 guidance. Analyst Commentary Bearish analysts are flagging a more cautious stance on Gerresheimer, pointing to reduced confidence in near term execution and visibility.
ナラティブの更新 • Apr 19

GXI: Reset After FY25 Warning Will Highlight Upside From Cautious FY26 Expectations

Gerresheimer's analyst price target has been revised lower to €44.18 from €45.95 as analysts factor in reduced short and mid term estimates following the recent FY25 warning and expectations that FY26 performance may sit near the low end of company guidance. Analyst Commentary The recent revision of the consensus price target to €44.18 reflects how analysts are resetting expectations after the FY25 warning and a more cautious view on FY26, which some see as closer to the low end of company guidance.
ナラティブの更新 • Apr 05

GXI: FY26 Guidance Anchor And Lowered Expectations Will Support Long-Term Confidence

The consensus analyst price target for Gerresheimer has decreased from about €34.17 to €24.40. Analysts cite reduced short- and mid-term estimates following the recent FY25 warning, and their FY26 expectations are now slightly below the low end of company guidance.
ナラティブの更新 • Mar 22

GXI: FY25 Warning And Deferred Results Will Pressure Shares Further

Analysts have reduced their price target for Gerresheimer to about €12.50 from around €18.90, citing lower short- and mid-term estimates following the recent FY25 warning and expectations that FY26 outcomes could sit near the low end of company guidance. Analyst Commentary Bearish analysts are signaling a more cautious view on Gerresheimer following the recent FY25 warning, with fresh price targets pointing to a more conservative stance on both earnings power and execution over the next few years.
ナラティブの更新 • Mar 07

GXI: Reset After FY25 Warning Will Set Up Future Earnings Reappraisal

Analysts have reduced their price target for Gerresheimer to about €46 from about €52, citing a higher discount rate and lower assumed future P/E, along with updated revenue growth and profit margin assumptions, as well as recent cautious Street research following the FY25 warning. Analyst Commentary The latest Street research has turned more cautious after the FY25 warning, with at least one major broker shifting to a Sell stance and cutting its price target to €12.90 from €29.
ナラティブの更新 • Feb 21

GXI: Deferred Results And Softer Outlook Will Keep Shares Fairly Priced

Analysts have adjusted their price target on Gerresheimer to €18.90 from €22.00 as they now apply a slightly higher discount rate, a lower assumed revenue growth rate, a modestly higher profit margin, and a reduced future P/E multiple. What's in the News Gerresheimer issued earnings guidance for 2026, targeting revenues of around €2.3b to €2.4b (company guidance).
分析記事 • Feb 10

Investors Don't See Light At End Of Gerresheimer AG's (ETR:GXI) Tunnel

Gerresheimer AG's ( ETR:GXI ) price-to-sales (or "P/S") ratio of 0.4x might make it look like a buy right now compared...
ナラティブの更新 • Feb 06

GXI: Index Inclusion And Higher P/E Assumptions Will Support Long-Term Confidence

Analysts have modestly lifted their price target for Gerresheimer, citing small adjustments to fair value and discount rate assumptions, as well as revised expectations for revenue growth, profit margins and future P/E. What's in the News Gerresheimer AG has been added to the Germany SDAX (Total Return) Index, highlighting its inclusion in this segment of the German equity market (Key Developments).
ナラティブの更新 • Jan 23

GXI: Reset Expectations Will Set Up Future Reappraisal Of Earnings Quality

Analysts have trimmed their average price target on Gerresheimer to €30 from €55. The change reflects updated expectations for revenue growth, profit margins and future P/E multiples following recent research reviews.
ナラティブの更新 • Jan 09

GXI: Profit Warnings Reset Expectations While Drug Delivery Platform Will Drive Reassessment

Gerresheimer's updated fair value estimate has been cut from about €97.07 to around €51.97 as analysts reset price targets sharply lower, citing reduced earnings visibility, a higher discount rate and increased uncertainty following recent profit warnings and rating downgrades. Analyst Commentary Recent Street research has turned more cautious on Gerresheimer, with several firms lowering price targets and adjusting ratings following profit warnings and reduced visibility on the investment case.
ナラティブの更新 • Dec 25

GXI: Profit Warnings And Weak Outlook Will Pressure Shares Further

Gerresheimer's analyst price target has been cut sharply from about EUR 47.50 to EUR 22.00, as analysts factor in lower growth, thinner margins, a higher discount rate, and reduced valuation multiples following multiple target downgrades and rising uncertainty around the investment case. Analyst Commentary Bearish analysts have made a series of aggressive downward revisions to Gerresheimer's valuation, cutting price targets from prior levels as high as EUR 99.30 to a range between EUR 23 and EUR 46.
ナラティブの更新 • Dec 11

GXI: Long-Term Sector Demand Will Support Confidence Despite Recent Profit Warnings

Analysts have cut their price target on Gerresheimer sharply, from roughly EUR 35 to about EUR 34. This reflects reduced fair value estimates as they factor in lower visibility on the investment case, successive target downgrades across the Street, and ongoing uncertainty following multiple profit warnings.
分析記事 • Nov 30

These 4 Measures Indicate That Gerresheimer (ETR:GXI) Is Using Debt In A Risky Way

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
ナラティブの更新 • Nov 27

GXI: Long-Term Sector Demand Will Support Confidence After Recent Leadership Change

Gerresheimer's analyst price targets have been significantly reduced recently, with analysts citing ongoing uncertainties and diminished near-term visibility as key factors for the downward revision. Previous targets exceeded €50, but new values are now in the €23 to €46 range.
ナラティブの更新 • Nov 10

GXI: Confidence Will Remain Despite Current Uncertainties And Leadership Transition

Gerresheimer's analyst fair value target has been revised downward from €37.84 to €34.62. This change reflects recent broad cuts in price targets by analysts, who cite low visibility and ongoing uncertainties around the company's outlook.
分析記事 • Nov 02

Lacklustre Performance Is Driving Gerresheimer AG's (ETR:GXI) 27% Price Drop

To the annoyance of some shareholders, Gerresheimer AG ( ETR:GXI ) shares are down a considerable 27% in the last...
ナラティブの更新 • Oct 27

Ongoing Uncertainties And Downgrades Will Shape Efficiency Efforts Ahead

Gerresheimer's analyst price target has been significantly reduced from €56.36 to €37.84. Analysts cite heightened uncertainties, reduced growth expectations, and a lack of near-term catalysts as reasons for this more cautious outlook.
ナラティブの更新 • Oct 13

New Production Lines In Lohr And Skopje Will Improve Efficiency

Analysts have lowered their price target for Gerresheimer from €63.72 to €56.36. They cite more cautious expectations for revenue growth and profitability going forward.
ナラティブの更新 • Sep 23

New Production Lines In Lohr And Skopje Will Improve Efficiency

The downward revision in Gerresheimer’s price target reflects recent declines in both net profit margin and consensus revenue growth forecasts, resulting in a reduced fair value estimate from €66.84 to €63.72. What's in the News Wolf Lehmann appointed as incoming CFO, succeeding Dr. Bernd Metzner; Lehmann brings nearly 30 years of international finance and management experience.
分析記事 • Sep 18

Why We're Not Concerned About Gerresheimer AG's (ETR:GXI) Share Price

When close to half the companies in Germany have price-to-earnings ratios (or "P/E's") below 18x, you may consider...
分析記事 • Jul 31

Here's Why Gerresheimer (ETR:GXI) Is Weighed Down By Its Debt Load

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
分析記事 • Jun 18

Positive Sentiment Still Eludes Gerresheimer AG (ETR:GXI) Following 28% Share Price Slump

Unfortunately for some shareholders, the Gerresheimer AG ( ETR:GXI ) share price has dived 28% in the last thirty days...
分析記事 • May 30

Shareholders May Be Wary Of Increasing Gerresheimer AG's (ETR:GXI) CEO Compensation Package

Key Insights Gerresheimer's Annual General Meeting to take place on 5th of June Salary of €1.15m is part of CEO Dietmar...
分析記事 • May 29

Gerresheimer (ETR:GXI) Is Due To Pay A Dividend Of €1.25

Gerresheimer AG ( ETR:GXI ) will pay a dividend of €1.25 on the 10th of June. Based on this payment, the dividend yield...
分析記事 • May 14

Is There Now An Opportunity In Gerresheimer AG (ETR:GXI)?

Gerresheimer AG ( ETR:GXI ), is not the largest company out there, but it led the XTRA gainers with a relatively large...
分析記事 • Apr 24

Gerresheimer (ETR:GXI) Is Due To Pay A Dividend Of €1.25

Gerresheimer AG ( ETR:GXI ) has announced that it will pay a dividend of €1.25 per share on the 10th of June. Based on...
分析記事 • Apr 19

Earnings Troubles May Signal Larger Issues for Gerresheimer (ETR:GXI) Shareholders

Gerresheimer AG's ( ETR:GXI ) recent weak earnings report didn't cause a big stock movement. However, we believe that...
分析記事 • Apr 11

It's Down 32% But Gerresheimer AG (ETR:GXI) Could Be Riskier Than It Looks

Gerresheimer AG ( ETR:GXI ) shares have had a horrible month, losing 32% after a relatively good period beforehand. The...
分析記事 • Apr 10

Gerresheimer (ETR:GXI) Will Pay A Dividend Of €1.25

Gerresheimer AG's ( ETR:GXI ) investors are due to receive a payment of €1.25 per share on 10th of June. This means the...
分析記事 • Mar 05

Gerresheimer (ETR:GXI) Has Announced A Dividend Of €1.25

The board of Gerresheimer AG ( ETR:GXI ) has announced that it will pay a dividend on the 10th of June, with investors...
分析記事 • Feb 25

Why Investors Shouldn't Be Surprised By Gerresheimer AG's (ETR:GXI) 25% Share Price Surge

Gerresheimer AG ( ETR:GXI ) shareholders would be excited to see that the share price has had a great month, posting a...
User avatar
新しいナラティブ • Feb 09

Expansion Into High-Margin Biologics And Devices Indicates Strong Future Prospects

Strategic expansion into high-margin segments like drug delivery systems and ready-to-use vials could enhance revenue and EBITDA margins significantly.
分析記事 • Jan 12

Is Gerresheimer (ETR:GXI) Using Too Much Debt?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
分析記事 • Dec 26

Is It Time To Consider Buying Gerresheimer AG (ETR:GXI)?

While Gerresheimer AG ( ETR:GXI ) might not have the largest market cap around , it saw significant share price...
分析記事 • Oct 03

Gerresheimer AG Just Missed EPS By 14%: Here's What Analysts Think Will Happen Next

It's been a mediocre week for Gerresheimer AG ( ETR:GXI ) shareholders, with the stock dropping 20% to €77.50 in the...
分析記事 • Sep 29

Is Gerresheimer (ETR:GXI) Using Too Much Debt?

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...
分析記事 • Aug 31

Gerresheimer AG's (ETR:GXI) Share Price Matching Investor Opinion

With a price-to-earnings (or "P/E") ratio of 31x Gerresheimer AG ( ETR:GXI ) may be sending very bearish signals at the...

業績と収益の成長予測

XTRA:GXI - アナリストの将来予測と過去の財務データ ( )EUR Millions
日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数
11/30/20282,680111N/A3687
11/30/20272,496855534212
11/30/20262,373573830212
11/30/20252,3093-8020912
8/31/20252,25023-439254N/A
5/31/20252,18863-468239N/A
2/28/20252,09079-549185N/A
11/30/20242,036110-130240N/A
8/31/20242,012114-131256N/A
5/31/20242,002115-54344N/A
2/29/20241,999117-15371N/A
11/30/20231,990116-44294N/A
8/31/20231,974107-27287N/A
5/31/20231,959107-80205N/A
2/28/20231,90497-89171N/A
11/30/20221,81796-38222N/A
8/31/20221,72591-45214N/A
5/31/20221,63482-20225N/A
2/28/20221,566854238N/A
11/30/20211,498846212N/A
8/31/20211,465861203N/A
5/31/20211,43293-13182N/A
2/28/20211,4189462243N/A
11/30/20201,4198948222N/A
8/31/20201,385-2553235N/A
5/31/20201,394-3226208N/A
2/29/20201,388-14-16165N/A
11/30/20191,3928128193N/A
8/31/20191,4152072161N/A
5/31/20191,410207N/A183N/A
2/28/20191,386179N/A159N/A
11/30/20181,368129N/A173N/A
8/31/20181,351124N/A184N/A
5/31/20181,329131N/A192N/A
2/28/20181,336137N/A206N/A
11/30/20171,348101N/A219N/A
8/31/20171,33149N/A184N/A
5/31/20171,35053N/A176N/A
2/28/20171,35856N/A190N/A
11/30/20161,37558N/A173N/A
8/31/20161,299118N/A195N/A
5/31/20161,292106N/A201N/A
2/29/20161,30199N/A188N/A
11/30/20151,28396N/A204N/A
8/31/20151,33569N/A206N/A

アナリストによる今後の成長予測

収入対貯蓄率: GXIの予測収益成長率 (年間42.7% ) は 貯蓄率 ( 1.9% ) を上回っています。

収益対市場: GXIの収益 ( 42.7% ) はGerman市場 ( 17.1% ) よりも速いペースで成長すると予測されています。

高成長収益: GXIの収益は今後 3 年間で 大幅に 増加すると予想されています。

収益対市場: GXIの収益 ( 5.1% ) German市場 ( 6.7% ) よりも低い成長が予測されています。

高い収益成長: GXIの収益 ( 5.1% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: GXIの 自己資本利益率 は、3年後には低くなると予測されています ( 8.2 %)。

成長企業の発掘

7D

1Y

7D

1Y

7D

1Y

企業分析と財務データの現状

データ最終更新日（UTC時間）
企業分析2026/06/22 13:58
終値2026/06/22 00:00
収益2025/08/31
年間収益2024/11/30

データソース

企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。

パッケージデータタイムフレーム米国ソース例
会社財務10年
  • 損益計算書
  • キャッシュ・フロー計算書
  • 貸借対照表
アナリストのコンセンサス予想+プラス3年
  • 予想財務
  • アナリストの目標株価
市場価格30年
  • 株価
  • 配当、分割、措置
所有権10年
  • トップ株主
  • インサイダー取引
マネジメント10年
  • リーダーシップ・チーム
  • 取締役会
主な進展10年
  • 会社からのお知らせ

* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。

特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。

分析モデルとスノーフレーク

このレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。

シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。

業界およびセクターの指標

私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。

アナリスト筋

Gerresheimer AG 12 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。34

アナリスト機関
Jonathon UnwinBarclays
Pallav MittalBarclays
Gaurav JainBarclays